skip to primary navigationskip to content

Dr. Acosta-Cabronero - Paper recently published in PLOS ONE

last modified Dec 05, 2013 03:47 PM
In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease

Over the last 2 years Dr Julio Acosta-Cabronero together with WBIC collaborators have been optimising the Magnetic Susceptibility MRI sequence and developing post processing methods.

This study presents a details methodological QSM framework for semi-automated magnetic susceptibility measurements and offers a proof of concept of its strong potential to yield new insights in neurodegenerative diseases such as Alzheimer’s disease.”

Follow the link:

WBIC Applications

Please click on the following buttons to view information on how to apply for scanning at the WBIC:




To find the next submission deadline for WBIC applications, please refer to the 'upcoming events' section below.